Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ: AVAHHealth CareMedical/Nursing ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AVAH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.69B
- P/E (TTM)
- 9.69
- Forward P/E
- 13.56
- EPS (TTM)
- $1.27
- Dividend yield
- None
- 52-week range
- 5.93 – 14.71
- Day range
- 12.14 – 12.55
- Volume / Avg
- 4.59M / 3.03M
- Beta
- —
- Shares outstanding
- 218.29M
- Next earnings
- Nov 5, 2026
52-week range
AVAH stock today
Aveanna Healthcare (AVAH) closed at $12.31 on Oct 7, up 0.74% (+$0.09), versus the S&P 500's 0.22% decline. At this level, AVAH sits in the middle of its 52-week range of $5.93 to $14.71: 16.3% below the high, set on Sep 16, 2026 and 107.6% above the low. AVAH is up 50.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 44.3%.
At 9.7x trailing earnings, Aveanna Healthcare trades below the peer-group median of 93.2x. Its forward P/E of 13.6x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Aveanna Healthcare's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Aveanna Healthcare
Company profileAveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Jeffrey S. Shaner
- Headquarters
- Atlanta, GA
- Employees
- 3,500
- IPO year
- 2021
- Website
- aveanna.com
Financial highlights
Full financialsIn fiscal 2026, Aveanna Healthcare generated $2.43 billion in revenue, up 20.2% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $225.0 million, for a net margin of 9.2% versus a median of -7.0% in the prior 5 years. Gross margin was 33.3% (up from 31.4%) and operating margin 10.5%.
| Fiscal year | FY 2026 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B |
| Growth | +20.19% | +6.82% | +6.02% | +6.50% | +12.27% |
| Net income | $225.03M | $-10.93M | $-134.52M | $-662.03M | $-117.04M |
| EPS (diluted) | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.69 |
Analyst forecast
ForecastConsensus (11 analysts)
buy
Avg. price target
$14.85+20.63%
- Strong buy 2
- Buy 6
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.19
- Last reported (Q2 2026)
- Aug 13, 2026
- EPS actual vs est.
- $0.18 vs —
AVAH news
All AVAH newsAveanna Healthcare peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRVAPrivia Health Group Inc. | 20.30 | +0.10% | $2.59B | vs AVAH |
| ADUSAddus HomeCare Corporation | 113.27 | +0.10% | $2.12B | vs AVAH |
| WGSGeneDx Holdings Corp. Class A | 68.53 | -4.18% | $2.04B | vs AVAH |
| LFSTLifeStance Health Group Inc. | 12.11 | -0.08% | $4.60B | vs AVAH |
| ALPSALPS Group Inc | 0.3444 | -10.71% | $57.31M | vs AVAH |
| EUDAEUDA Health Holdings Limited | 19.04 | -0.58% | $57.01M | vs AVAH |
| DCGODocGo Inc. | 0.345 | -4.70% | $34.15M | vs AVAH |
| CCMConcord Medical Services Holdings Limited ADR | 3.13 | -2.19% | $13.57M | vs AVAH |
Indexes, lists and sector
Aveanna Healthcare stock FAQ
What is Aveanna Healthcare's stock price today?
AVAH last traded at $12.31 as of Oct 7, 4:00 PM EDT, up 0.74% on the day. Prices are delayed at least 15 minutes.
When is Aveanna Healthcare's next earnings date?
Aveanna Healthcare is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.19.
What is AVAH's P/E ratio?
AVAH trades at a trailing P/E ratio of 9.69 and a forward P/E of 13.56, compared with a median of 93.2 for its closest peers.
Who is Aveanna Healthcare's CEO?
Mr. Jeffrey S. Shaner is the chief executive officer of Aveanna Healthcare Holdings Inc., which has about 3,500 employees.
What is the AVAH 52-week high?
The 52-week high for AVAH is $14.71 and the 52-week low is $5.93. The stock is currently 16.3% below its high.